BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Prognosis
27 results:

  • 1. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach.
    Kartal B; Denizler-Ebiri FN; Güven M; Taşpınar F; Canpınar H; Çetin S; Karaduman T; Küççüktürk S; Castresana J; Taşpınar M
    Med Oncol; 2024 Mar; 41(5):97. PubMed ID: 38532150
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Is intraoperative electrocorticography (ECoG) for long-term epilepsy-associated tumors (LEATs) more useful in children?-A Randomized Controlled Trial.
    Rajeev SP; Darshan HR; Vilanilam GC; Abraham M; Keshavapisharady K; Venkat EH; Stanley A; Menon RN; Radhakrishnan A; Cherian A; Narasimaiah D; Thomas B; Kesavadas C; Vimala S
    Childs Nerv Syst; 2024 Mar; 40(3):839-854. PubMed ID: 38010434
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Maxillary gingival neurolemmoma: a case report and literature review.
    Zhang X; Gao Q; Xuan Y
    BMC Oral Health; 2023 Oct; 23(1):770. PubMed ID: 37858072
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long-term Cancer Survival Trends by Updated Summary Stage.
    Forjaz G; Ries L; Devasia TP; Flynn G; Ruhl J; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1508-1517. PubMed ID: 37623930
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
    Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
    Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Watching the clock in glioblastoma.
    Chan P; Rich JN; Kay SA
    Neuro Oncol; 2023 Nov; 25(11):1932-1946. PubMed ID: 37326042
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.
    Xuan W; Hsu WH; Khan F; Dunterman M; Pang L; Wainwright DA; Ahmed AU; Heimberger AB; Lesniak MS; Chen P
    Cancer Immunol Res; 2022 Jun; 10(6):770-784. PubMed ID: 35413115
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trial.
    Hagel C; Sloman V; Mynarek M; Petrasch K; Obrecht D; Kühl J; Deinlein F; Schmid R; von Bueren AO; Friedrich C; Juhnke BO; Gerber NU; Kwiecien R; Girschick H; Höller A; Zapf A; von Hoff K; Rutkowski S
    Eur J Cancer; 2022 Mar; 164():30-38. PubMed ID: 35151105
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Optimal Volume of the Residual tumor to Predict Long-term tumor Control Using Stereotactic Radiosurgery after Facial Nerve-preserving Surgery for Vestibular Schwannomas.
    Lee WJ; Lee JI; Choi JW; Kong DS; Nam DH; Cho YS; Shin HJ; Seol HJ
    J Korean Med Sci; 2021 Apr; 36(16):e102. PubMed ID: 33904259
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
    Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
    J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Expression and significance of programmed cell death ligand-1 in neuroblastoma tissues].
    Liao R; Sun XF; Zhen ZZ; Huang DS
    Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):735-740. PubMed ID: 30293276
    [No Abstract]    [Full Text] [Related]  

  • 12. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
    Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
    Lassaletta A; Zapotocky M; Mistry M; Ramaswamy V; Honnorat M; Krishnatry R; Guerreiro Stucklin A; Zhukova N; Arnoldo A; Ryall S; Ling C; McKeown T; Loukides J; Cruz O; de Torres C; Ho CY; Packer RJ; Tatevossian R; Qaddoumi I; Harreld JH; Dalton JD; Mulcahy-Levy J; Foreman N; Karajannis MA; Wang S; Snuderl M; Nageswara Rao A; Giannini C; Kieran M; Ligon KL; Garre ML; Nozza P; Mascelli S; Raso A; Mueller S; Nicolaides T; Silva K; Perbet R; Vasiljevic A; Faure Conter C; Frappaz D; Leary S; Crane C; Chan A; Ng HK; Shi ZF; Mao Y; Finch E; Eisenstat D; Wilson B; Carret AS; Hauser P; Sumerauer D; Krskova L; Larouche V; Fleming A; Zelcer S; Jabado N; Rutka JT; Dirks P; Taylor MD; Chen S; Bartels U; Huang A; Ellison DW; Bouffet E; Hawkins C; Tabori U
    J Clin Oncol; 2017 Sep; 35(25):2934-2941. PubMed ID: 28727518
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
    Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G
    Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2.
    Liang J; Cao R; Wang X; Zhang Y; Wang P; Gao H; Li C; Yang F; Zeng R; Wei P; Li D; Li W; Yang W
    Cell Res; 2017 Mar; 27(3):329-351. PubMed ID: 28035139
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.
    Li B; Wan X; Liang Y; Lu B; Lu W
    J Reprod Med; 2016 Sep; 61(9-10):494-502. PubMed ID: 30383951
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
    Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
    Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.
    Zhao M; Xu H; Liang F; He J; Zhang J
    Tumour Biol; 2015 Jan; 36(1):429-36. PubMed ID: 25266800
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hydatidiform mole and its complications: review of patient profiles and management at the university of the Philippines-Philippine General Hospital.
    Cagayan MS
    J Reprod Med; 2014; 59(5-6):235-40. PubMed ID: 24937963
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
    Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
    Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.